Found "Digital Medicine": 213 results
Sort by
Z - A

Navigating the Landscape of Digital Health: Australia

Executive Summary Australia has a history of innovation, which is reflected in the breadth of health technologies that are increasingly available in the country’s digital health landscape. This breadth of digital health technologies can be categorised across four domains: Software as a Medical De

Navigating the landscape of Digital Health

To understand the digital health landscape in different countries from national strategy and regulation to HTA evaluation, adoption, and challenges. The objective is to use this information to better inform digital health policy in Thailand as well as to create a reference case to conduct HTA for digital health technologies.

Nationwide survey of nutritional management in an Asian upper-middle income developing country government hospitals: Combination of quantitative survey and focus group discussion (2016)

K. Chittawatanarat a, *, K. Tosanguan b, U. Chaikledkaew b, c, S. Tejavanija d, Y. Teerawattananon b a Division of Trauma and Critical Care, Department of Surgery, Faculty of Medicine, Maharaj Nakorn Chiang Mai Hospital, Intawarorod Road, Sripume, Chiang Mai University, Chiang Mai 50200, Thailand

My Experience Attending PMAC 2018 Conference

Last month, I had the opportunity to attend the PMAC 2018 conference. I cannot help myself expressing immense pleasure to be a part as a participant in the mega event where I met many intelligent and sharp international colleagues and one health expert from different one health global netwo

Methods for Economic Evaluation Project (MEEP)

Priority setting decisions in health policy are unavoidable. Priority setting has inevitable consequences in terms of foregone health benefits. Decisions can be optimized by ensuring that decision makers have clarity about both the costs and benefits of different options. The use of economic evaluation methods can provide a systematic approach to r

Merck osteoporosis drug, company pipeline win more respect

Merck, the second-biggest U.S. drugmaker, on Wednesday said outside monitors recommended that its late-stage study of odanacatib, a new type of treatment, be stopped early because data has already shown it reduces fractures. Shares of Merck rose 4.2 percent on Thursday, on boosted hopes for the medi

Medicaid expansion in U.S. states found to cut death rates

The findings published in the New England Journal of Medicine could fuel a political furor over new plans for a nationwide expansion of Medicaid that erupted after the U.S. Supreme Court’s ruling to uphold President Barack Obama’s healthcare law in late June.In an unexpected move, the high court rul

Mapping the value for money of precision medicine: a systematic literature review and meta-analysis

About the study Objective: This study aimed to quantify heterogeneity in the value for money of precision medicine (PM) by application types across contexts and conditions and to quantify sources of heterogeneity to areas of particular promises or concerns as the field of PM moves forward. Methods

Lower costs may mean more patients stick with meds

(Reuters Health) – When people with chronic health conditions have lower out-of-pocket costs for medications, they are more likely to actually fill their prescriptions, according to a new research review.The findings, reported in the Annals of Internal Medicine, sound logical. But they lend some har

Kinanti Khansa Chavarina

Kinanti Khansa Chavarina is an Associate at the International Unit of the Health Intervention and Technology Assessment Program (HITAP) Foundation in Thailand. Her work focuses on health policy and systems research, such as scoping and systematic reviews, qualitative analysis, and economic evaluation. Her research interests include health policy, h
10 / Page